iBet uBet web content aggregator. Adding the entire web to your favor.
iBet uBet web content aggregator. Adding the entire web to your favor.



Link to original content: https://pubmed.ncbi.nlm.nih.gov/29192287/
Next generation antibody drugs: pursuit of the 'high-hanging fruit' - PubMed Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Mar;17(3):197-223.
doi: 10.1038/nrd.2017.227. Epub 2017 Dec 1.

Next generation antibody drugs: pursuit of the 'high-hanging fruit'

Paul J Carter  1 , Greg A Lazar  1
Affiliations
Review

Next generation antibody drugs: pursuit of the 'high-hanging fruit'

Paul J Carter et al. Nat Rev Drug Discov. 2018 Mar.

Abstract

Antibodies are the most rapidly growing drug class and have a major impact on human health, particularly in oncology, autoimmunity and chronic inflammatory diseases. Many of the best understood and most tractable cell surface and secreted targets with known roles in human diseases have been extensively exploited for antibody drug development. In this Review, we focus on emerging and novel mechanisms of action of antibodies and innovative targeting strategies that could extend their therapeutic applications, including antibody-drug conjugates, bispecific antibodies and antibody engineering to facilitate more effective delivery. These strategies could enable the pursuit of difficult to hit, less well-understood or previously undruggable targets - the 'high-hanging fruit'.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Cancer Cell. 2011 Jan 18;19(1):101-13 - PubMed
    1. ISRN Oncol. 2013 Jun 11;2013:371854 - PubMed
    1. J Immunol. 2009 Jun 15;182(12):7663-71 - PubMed
    1. Cancer Res. 2004 Mar 15;64(6):2127-33 - PubMed
    1. BioDrugs. 2016 Jun;30(3):195-206 - PubMed

Publication types

MeSH terms

LinkOut - more resources